Daily Briefing

4 minute read

Cancer rates expected to skyrocket worldwide


According to a recent report from the World Health Organization (WHO), annual cancer rates are projected to rise 67% globally by 2050, going from roughly 20.6 million people diagnosed with cancer in 2024 to around 35 million — emphasizing a need to invest more in programs for cancer prevention and treatment.

Cancer rates expected to rise significantly, especially in low-income countries

The expected rise in cancer rates is largely driven by exposure to known risk factors, such as smoking and alcohol, and an aging population, according to the report. Experts have also cited improvements in cancer surveillance, which has allowed doctors to diagnose more cancers than in the past.

"It will be a significant added burden for every country globally when cancers associated with obesity become the norm," said André Ilbawi, team lead for cancer control at WHO. "That will likely happen in a significant number of countries in the next 20 to 30 years."

In the United States, the rate of new cancer cases has been generally stable in recent years, according to NIH. However, the WHO report projects that cancer rates will increase in all regions of the world, with new cases expected to disproportionately appear in lower-income countries with less access to cancer surveillance and treatment.

Although incidence rates of cancer are increasing, the report noted that cancer survival rates have also improved. In high-income countries, five-year net survival rates for breast and prostate cancer are currently around 80% to 90%.

 

 

"Cancer is not just a medical diagnosis – it profoundly, indefinitely affects every aspect of a person's life, and their family's as well." 

However, cancer survival rates are much lower in low-income countries. In high-income countries, the five-year net survival rate for breast cancer exceeds 85%, but in low-income countries, that number drops below 30%.

Isabelle Soerjomataram, an epidemiologist with the International Agency for Research on Cancer, said that cervical cancer has been reduced to "almost elimination" in parts of Europe and North America, but in "many countries of sub-Saharan Africa, it is still the top, number one cancer."

Abigail Simon-Hart, a breast cancer survivor and patient advocate from Nigeria, said that she's seen "parents choose between paying for treatment and keeping a child in school, and children forced to abandon their education because every single available resource was spent on cancer care."

Simon-Hart added that in some places, the stigma surrounding a cancer diagnosis could be deadly. During her work, she said she's met women who chose to die instead of losing a breast to life-saving mastectomies.

Report calls on countries to invest in cancer prevention and treatment

Both high- and low-income countries are not investing enough in cancer prevention and treatment, the report said; however, it highlighted some moderate progress in curbing some practices and conditions that can cause cancer.

The report praised worldwide progress in adopting measures to reduce tobacco use, which has dropped 27% since 2010. In addition, 85% of countries now include vaccines for human papillomavirus in their national vaccine programs, and an estimated 31% of girls have received the first dose of the vaccine, up from 17% in 2019.

The report called on governments, international organizations, civil society, academic institutions, the private sector, and WHO to all work together to provide a people-centered and holistic approach to care for individuals and families affected by cancer.

"Cancer is not just a medical diagnosis – it profoundly, indefinitely affects every aspect of a person's life, and their family's as well," said Clarissa Schilstra, a childhood cancer survivor and lead of WHO's report. "We urge policymakers to meaningfully engage with people affected by cancer. By voicing our lived experiences, we can inform more equitable, effective solutions to protect and promote the lives and wellbeing of future generations."

Specifically, the report outlines three strategic recommendations to be implemented worldwide:

  1. Better capabilities: Integrating cancer control within universal health coverage and investing in human capital to prevent and control cancer
  2. Better protections: Placing those with lived experiences in the middle of cancer systems while strengthening social protection
  3. Better value: Aligning research and innovation with public health needs and ensuring equitable access to value-based advances in cancer care

"Cancer is a deeply personal disease that touches nearly all of us. But whether a person survives cancer should never depend on where they were born or what they earn," said WHO Director-General Tedros Adhanom Ghebreyesus. "The inequities documented in this report are not inevitable; they are the consequence of choices, and they can be reversed through stronger and unified action."

(Wu, Washington Post, 7/8; Lay, The Guardian, 7/8; WHO press release, 7/8)


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

INDUSTRY SECTORS

RELATED RESOURCES

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece

Email ask@advisory.com to learn more

Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board

Never miss out on the latest innovative health care content tailored to you. 

Benefits Include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

This is for members only. Learn more.

Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board

Never miss out on the latest innovative health care content tailored to you. 

Benefits Include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.